The smart insulin pens are either prefilled or reusable that is used to treat type 1 diabetes and type 2 diabetes. The second-generation smart insulin pens are devices that are engineered with Bluetooth or USB features to enable closer monitoring. The main types of smart insulin pens are first-generation pens and second-generation pens (Bluetooth enabled, USB connected). It is connected with a smartphone app that automatically records the dosing information of each injection and provides assistance with dosing. The smart insulin pens are injector pens with the needle that help people with diabetes to manage insulin delivery. The smart insulin pens market consists of sales of smart insulin pens which allows to dial the insulin dose accurately and related products. Hoffmann-La Roche AG, Insulet Corporation, Jiangsu Delfu medical device Co. Ltd., Emperra GmbH E-Health Technologies, Digital Medics Pvt Ltd., F. Major players in the market are Companion Medical, Eli Lilly and Company, Novo Nordisk A/S, Diamesco Co.

The market is expected to grow to $0.12 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The global smart insulin pens market is expected to grow from $0.09 billion in 2021 to $0.09 billion in 2022 at a compound annual growth rate (CAGR) of 7.2%. DUBLIN-( BUSINESS WIRE)-The 'Global Smart Insulin Pens Market Report 2022' report has been added to 's offering.

Driver booster key 6.3